https://www.selleckchem.com/pr....oducts/semaglutide.h
In idiopathic sudden sensorineural hearing loss (ISSNHL), the relationship between the administration duration of vitamin B12 (vit B12) with adenosine triphosphate (ATP) and their therapeutic effect is not fully understood. To investigate the therapeutic effect of long-term 16 (≥weeks) administration of vit B12 with ATP on the prognosis of ISSNHL patients and compare it with those of short-term (8 weeks) and middle-term (≥8 weeks, 16 weeks) administration. We retrospectively reviewed the medical records of 117 patients with
Like
Comment
Share
